Project Grant R56ES034386
Award Date
8/20/23
Completion Date
7/31/24
Dollars Obligated
$463K
Funding Federal Agency
Office of the Director
Awarding Federal Agency
National Institute of Environmental Health Sciences
Federal Grant Program
93.310
Assistance Type
Project Grant
Place of Performance
Aurora, CO 80045, USA
Similar Awards
This federal Project Grant award, provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), supports research aimed at understanding the mechanisms underlying mast cell expansion and function in human airway diseases, including asthma and nasal polyposis. The $715,968 award to Brigham & Women's Hospital Inc., a subsidiary of Partners Healthcare System Incorporated, will fund a 5-year project to investigate the...
This Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to enhance understanding of the regulation of mast cell genes that influence allergy susceptibility and severity. The $612,328 award to National Jewish Health will investigate how the transcription factor MITF promotes mast cell-specific gene expression while suppressing basophil-specific genes. The...
This Project Grant award of $387,116 from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports research at the University of South Florida to investigate the mechanisms underlying house dust mite-induced airway hyperreactivity, a key symptom of asthma. The research aims to define the specific sensory nerve populations and signaling pathways triggered by house dust mite exposure that lead to the development of airway hyperreactivity, in order to...
The Project Grant award R56ES034423 from the Department of Health and Human Services National Institutes of Health (NIH) Trans-NIH Research Support program (CFDA 93.310) provides $445,500 to the University of Alabama at Birmingham (UAB) to study the role of extracellular vesicles (EVs) and exosomes as mediators of injury from inhaled exposures to toxic chemicals such as sulfur mustard and chlorine. The project aims to: (A) characterize EVs/exosomes derived from the bronchoalveolar lavage fluid...
This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $317,239 to the University of Texas Medical Branch at Galveston (UTMB) to investigate conserved inflammatory mechanisms of vesicant-induced skin injury. The research aims to map the distribution of transcriptional pathways and biomediators associated with localized damage from exposure to sulfur mustard and lewisite vesicants using...
This $299,993 Project Grant awarded by the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310) supports the development of CMTX Biotech's drug candidate Incyclinide (CMT-3/COL-3) as a medical countermeasure for sulfur mustard-induced lung injury. The key objectives are to: Demonstrate a dose-dependent survival benefit of Incyclinide in a rat model of sulfur mustard inhalation exposure, with daily treatment beginning 24 hours post-exposure. Evaluate...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $872,914 to Tulane University to conduct research on "Mast Cell Activation as a Mediator of Persistent Neurological Symptoms Partly Mediated Through a Novel Matrix Metalloproteinase." The award period runs from September 1, 2024 to August 31, 2027. The Military Medical Research and Development program supports a broad range of biomedical research...
This $445,500 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) will fund research by the University of Alabama at Birmingham (UAB) to investigate the role of proteolytic extracellular vesicles (EVs) in mediating chronic lung injury after exposure to chlorine (Cl2) or bromine (Br2) gas. The key objectives are to determine how PMN-derived EVs containing neutrophil elastase (NE) contribute to the...
This Project Grant award, with a total funding of $5,963,305.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the continued clinical development of a novel pleural and tracheal sealant. The primary award recipient is the University of Vermont & State Agricultural College. A sub-award of an unspecified amount was provided to the University of Connecticut Health Center to support this research effort. The funding will...
This Project Grant award of $260,000.00 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) will support research to explore the basic molecular mechanism underlying skin blistering caused by exposure to chemical weapons. The University of Chicago, the awardee, will employ an integrative approach to investigate how skin vesicants, such as phenylarsine oxide and nitrogen...